Pediatrics Doctors in Rockport, ME Accepting Medicare

6 Pediatrics doctors found. Showing 1 - 6

William B Stephenson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7 Madelyn Ln, Suite B, Rockport, ME 04856 Phone: 207-593-5600    Fax: 207-593-5360

Dr. Karl Christian Santiago, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7 Madelyn Ln Ste B, Rockport, ME 04856 Phone: 207-301-5600    Fax: 207-301-5360

Dr. Margaret Elizabeth Kloby, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7 Madelyn Ln Ste B, Rockport, ME 04856 Phone: 207-921-5600    Fax: 207-921-5360

Dr. Adeline Winkes, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Pen Bay Pediatrics, 15 Anchor Dr., Rockport, ME 04856 Phone: 207-921-5600    Fax: 207-921-5360

Alison Faulkingham, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1056 Commercial St, Rockport, ME 04856 Phone: 207-596-6722    Fax: 207-596-6709

Dr. Peter Clifford Vickerman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7 Madelyn Ln, Suite B, Rockport, ME 04856 Phone: 207-593-5600    Fax: 207-593-5360

News Archive

DOJ investigates alleged fraud by drugmakers; sanctions on wellcare lifted

"A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry," Business Week reports. "Critics say the continuing probe, which involves Johnson & Johnson (JNJ) and other major drugmakers, highlights what they describe as an industry practice of paying money to outfits that provide drugs to consumers, in return for preferential treatment."

Persistent infection in infant reveals mutation that helps bacteria tolerate antibiotic therapy

The quest to understand a prolonged infection in an infant being treated for leukemia has led to the St. Jude Children's Research Hospital discovery of a mutation that allows bacteria to tolerate normally effective antibiotic therapy. The report appears today in the scientific journal mBio.

Gridlock continues despite push to reach debt-ceiling deal

Democratic and Republican leaders are preparing their own backup plans as possibilities for a bipartisan approach appear increasingly dim. Both political and policy-oriented differences are making the process difficult. Medicare, Medicaid, other entitlement programs and even Tricare are in play. All the while, the deadline continues its approach.

Shire receives FDA Fast Track designation for REPLAGAL

Shire plc, the global specialty biopharmaceutical company, announces it has received Fast Track designation from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease.

Smartphone app could be used to screen for pancreatic cancer

Scientists have created an app that uses Smartphone selfies to detect pancreatic cancer while it is in the early stages.

Read more Medical News

› Verified 6 days ago